Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL21700410

CC(=O)Nc1ccc(/N=N/c2c(N)ccc3cc(S(=O)(=O)O)cc(O)c23)c(S(=O)(=O)O)c1.N.N

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 7/20 0.81
APEX1 P27695 2/20 0.52
SUMO2 P61956 2/20 0.51
SUMO1 P63165 2/20 0.51
SENP7 Q9BQF6 2/20 0.51
SENP2 Q9HC62 2/20 0.51
CYP1A2 P05177 1/20 0.47
CD40 P25942 1/20 0.44
CD40LG P29965 1/20 0.44
NT5E P21589 1/20 0.44
SENP3 Q9H4L4 1/20 0.43
SENP1 Q9P0U3 1/20 0.43
PRMT1 Q99873 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
AMY1A P0DUB6 1/20 0.41
PRMT3 O60678 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12994564 0.99 ENPP2 (0.82) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL29637807 0.91 ENPP2 (0.85) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL30716918 0.91 ENPP2 (0.85) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL10891093 0.91 ENPP2 (0.85) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL10891071 0.91 ENPP2 (0.85) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL11594349 0.91 ENPP2 (0.85) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL11594336 0.90 ENPP2 (0.84) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL15113011 0.90 ENPP2 (0.68) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL11762276 0.89 ENPP2 (0.78) ENPP2APEX1SUMO2SUMO1SENP7
SCHEMBL11763856 0.88 ENPP2 (0.96) ENPP2APEX1SUMO2SUMO1SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3864140-B1 ANALYSIS OF VIABLE AND NONVIABLE CELLS SAGEMEDIC CORP (US) 2025-05-21 EP disclosed
US-11726039-B2 Analysis of viable and nonviable cells SageMedic Corporation (US) 2023-08-15 US disclosed
EP-3864140-A1 ANALYSIS OF VIABLE AND NONVIABLE CELLS SageMedic, Corp. (US) 2021-08-18 EP disclosed
US-20210190688-A1 ANALYSIS OF VIABLE AND NONVIABLE CELLS SAGEMEDIC CORP (US) 2021-06-24 US disclosed
US-10883936-B2 Analysis of viable and nonviable cells SageMedic Corporation (US) 2021-01-05 US disclosed
WO-2020077290-A9 ANALYSIS OF VIABLE AND NONVIABLE CELLS SageMedic Corporation (US) 2020-11-12 WO disclosed
US-20200116635-A1 ANALYSIS OF VIABLE AND NONVIABLE CELLS SAGEMEDIC CORP (US) 2020-04-16 US disclosed
US-10564100-B1 Analysis of viable and nonviable cells SageMedic Corporation (US) 2020-02-18 US disclosed